Procedure Enabled by Dextera Surgical’s MicroCutter 5/80 to be Featured at Society of Thoracic Surgeons 2017

-- Less Invasive Uniportal Lobectomy Highlighted --

REDWOOD CITY, Calif.--()--Dextera Surgical Inc. (Nasdaq: DXTR), manufacturer of the smallest-profile and most maneuverable articulating surgical stapling platform on the market for minimally invasive surgery, today announced that the company’s MicroCutter 5/80 will be featured in a presentation highlighting Uniportal Lobectomy performed through a single incision in the subxiphoid or subcostal space, at The Society of Thoracic Surgeons and American Association for Thoracic Surgery’s Tech Conference (TechCon) in Houston, Texas.

This less invasive approach to the lobectomy procedure using Dextera Surgical’s MicroCutter 5/80 surgical stapling technology will be presented by Joel Dunning, M.D., cardiothoracic surgeon at James Cook University Hospital, Department of Cardiothoracic Surgery in Middlesbrough, U.K. Dr. Dunning’s presentation, entitled “Subxiphoid and Subcostal Uniportal Lobectomy” will take place Saturday, January 21 at 11:37 a.m. CST, in the General Thoracic Track II: Advanced Thoracic Surgery, room 310ABC.

MicroCutter Indication Information

The MicroCutter 5/80 Stapler is manufactured and cleared for use in the United States for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the small and large intestine, and the transection of the appendix. The MicroCutter 5/80 may be used with both MicroCutter 30 White Reloads in vascular/thin tissue and MicroCutter 30 Blue Reloads for medium tissue.

About Dextera Surgical

Dextera Surgical (Nasdaq:DXTR) designs and manufactures proprietary stapling devices for minimally invasive surgical procedures. In the U.S., surgical staplers are routinely used in more than one million minimally invasive laparoscopic, video-assisted or robotic-assisted surgical procedures annually.

Dextera Surgical also markets the only automated anastomosis devices for coronary artery bypass graft (CABG) surgery on the market today: the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System. These products, sold by Dextera Surgical under the Cardica brand name, have demonstrated long-term reliable clinical performance for more than a decade.

Contacts

Dextera Surgical Inc.
Investors:
Bob Newell, 650-331-7133
Vice President, Finance and Chief Financial Officer
investors@dexterasurgical.com
or
Media:
Jessica Volchok, 310-849-7985
jessica@nicoleosmer.com

Contacts

Dextera Surgical Inc.
Investors:
Bob Newell, 650-331-7133
Vice President, Finance and Chief Financial Officer
investors@dexterasurgical.com
or
Media:
Jessica Volchok, 310-849-7985
jessica@nicoleosmer.com